000 | 00940 a2200277 4500 | ||
---|---|---|---|
005 | 20250513235545.0 | ||
264 | 0 | _c20010628 | |
008 | 200106s 0 0 fre d | ||
022 | _a0398-0499 | ||
040 |
_aNLM _beng _cNLM |
||
100 | 1 | _aGuilmot, J L | |
245 | 0 | 0 |
_a[Diabetic arteriopathy. Microcirculation, an inevitable therapeutic objective]. _h[electronic resource] |
260 |
_bJournal des maladies vasculaires _cApr 2001 |
||
300 |
_a135-41 p. _bdigital |
||
500 | _aPublication Type: English Abstract; Journal Article; Review | ||
650 | 0 | 4 | _aAnimals |
650 | 0 | 4 |
_aDiabetic Angiopathies _xphysiopathology |
650 | 0 | 4 |
_aEpoprostenol _xphysiology |
650 | 0 | 4 | _aHumans |
650 | 0 | 4 |
_aMicrocirculation _xphysiopathology |
650 | 0 | 4 |
_aNitric Oxide _xphysiology |
650 | 0 | 4 | _aRegional Blood Flow |
700 | 1 | _aDiot, E | |
700 | 1 | _aBoissier, C | |
773 | 0 |
_tJournal des maladies vasculaires _gvol. 26 _gno. 2 _gp. 135-41 |
|
999 |
_c11253585 _d11253585 |